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P ost-traumatic stress disorder (PTSD) is a stress- related mental disorder caused by exposure to 
severe traumatic events,  such as war,  violent personal 
assault,  or natural disasters,  and PTSD is characterized 
by intrusive memories (flashbacks),  hyperarousal,  and 
avoidance symptoms.  The pathophysiology of PTSD is 
still unclear,  but both fear conditioning and sensitiza-
tion are thought to play crucial roles [1].  Various hypo-
thalamo-pituitary-adrenal (HPA) axis abnormalities 
have also been reported in a PTSD-enhanced suppres-
sion of cortisol in response to an administration of 
dexamethasone (DEX) [2 , 3].  Generally speaking,  ani-
mal models of anxiety including those of PTSD can be 
grouped into two main classes: the first involves the 
conditioned responses of animals to stressful and often 
painful events such as electric foot-shock,  and the sec-
ond includes ethology-based protocols and involves the 
spontaneous or natural reactions of animals such as 
flight,  avoidance,  or freezing,  to investigate stimuli that 
do not explicitly involve pain or discomfort [4].  Most 
models involve the exposure of subjects to external cues 
paired with either foot shock,  bright light,  or a preda-
tor,  or internal cues such as drug-state stimuli that are 
assumed capable of inducing anxiety in animals [5].
In the case of PTSD,  the mouse model involving 
repeated exposures to conditioned fear (CF) stress and 
the rat model involving single prolonged stress (SPS) are 
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We tried to clarify the applicability of a single prolonged stress (SPS) protocol as post-traumatic stress disorder 
(PTSD) model in mice.  To investigate PTSD pathophysiology,  we conducted hypothalamo-pituitary-adrenal 
(HPA) negative feedback testing at 1,  4,  8 and 12 weeks after the SPS by administrating a dexamethasone (DEX) 
suppression test.  The SPS induced over-suppression of the HPA system by DEX treatment at 8 and 12 weeks.  To 
investigate PTSD-like behavioral characteristics,  we subjected mice to testing in a light/dark box (to assess anx-
iety),  a Y-maze (working memory),  a cliff avoidance (visual cognition),  and an open field (locomotor activity) 
at 1,  4,  8 and 12 weeks after the SPS.  In the light/dark box test,  the SPS-applied mice spent significantly less 
time in the light box at 8 or 12 weeks.  In the cliff avoidance test,  the SPS-applied mice spent significantly less 
time in the open area at 1 week.  However,  in both the Y-maze test and the open field test,  SPS-applied mice 
tended toward slight decreases in a time-dependent manner until 12 weeks.  Therefore,  SPS-applied mice may 
thus be useful for assessing characteristics relevant to PTSD that coincide with changes in the HPA axis.
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the two common animal models for PTSD research 
[3 , 6].  The CF mouse model shows specific fear 
responses,  called contextual fear and cued fear,  to 
training environments and cues [6].  However,  that 
model cannot mimic all of the symptoms of PTSD 
patients.  For example,  it is difficult to use the CF model 
to investigate the function of HPA axis and some cere-
bral changes in PTSD pathophysiology [3].  The SPS 
model induces an overexpression of glucocorticoid 
receptors,  low levels of plasma glucocorticoid (which is 
related to the HPA system),  and other cerebral changes,  
such as hippocampal atrophy,  that are similar to 
changes seen in PTSD patients [7].  The over-suppres-
sion of the HPA system has been observed in PTSD 
patients as a typical phenomenon.  The most important 
advantage of the SPS model in rats is that a single expo-
sure to a stressor can induce long-lasting effects of 
behavioral and neurological changes as typical symp-
toms of PTSD [3].  As a result,  the rat SPS model is 
widely used to explore changes in the above symptoms 
in a PTSD-like pathophysiology [8].  However,  the SPS 
model was established mainly in rats.  We hypothesized 
that there were likely to be no significant differences 
between rats and mice when PTSD-like symptoms are 
evaluated.
In this study,  we attempted to clarify the applicabil-
ity of the SPS model of PTSD to mice instead of rats,  
not only to save space and experimental equipment,  but 
also to enable the use in PTSD research of genetic engi-
neering techniques such as genetic recombination and 
gene analyses,  for which mice are frequently used.
Materials and Methods
All reagents and chemicals were of the highest com-
mercial grade available.  All of the behavioral studies 
were performed with male ICR mice (Clea Japan,  Tokyo,  
Japan),  aged 8-9 weeks.  Mice were provided free access 
to food and water while being housed in groups at con-
stant room temperature (24 ± 1°C) and humidity (55%) 
with a 12 h light/12 h dark cycle (lights on at 07 : 00  
h) for 1 week before the experiments.  The principles of 
laboratory animal care and all experimental procedures 
were in strict accordance with the Guidelines for 
Animal Experiments of the Shujitsu University School 
of Pharmacy.
The experimental procedure was modified from a 
previous method [3].  Briefly,  the SPS protocol was con-
ducted in three stages: the mouse are restrained for 2 h 
and then immediately underwent a 20-min forced swim 
in 3 L of 25°C water in a 5-L glass beaker.  Following a 
15-min recuperation period,  the mouse was exposed to 
ether until it lost consciousness.  The mouse was then 
left in its home cage until the behavioral analysis.
To confirm the pathophysiology of PTSD,  we sub-
jected the mice to HPA negative feedback testing at 1,  
4,  8,  and 12 weeks after the application of the SPS pro-
tocol.  First,  the mice were tested for the SPS-applied 
effect on a dexamethasone (DEX) suppression of plasma 
corticosterone to test the effects of the SPS protocol.  We 
divided the mice into four groups: control+saline,  n=6;  
control+DEX,  n=6; SPS+saline,  n=7; and SPS+DEX,  
n = 7.  The control and SPS-applied mice received a sub-
cutaneous injection of either DEX (0.05 mg/kg; Sig-
ma-Aldrich,  St. Louis,  MO,  USA) or normal sterile 
saline.  Blood was collected via the caudal vein for the 
measurement of corticosterone.  The collected blood 
samples were centrifuged at 6,000g for 5 min to collect 
plasma.  Plasma corticosterone levels were measured 
using a commercially available enzyme-linked immu-
nosorbent assay (ELISA) kit (AssayPro,  St. Charles,  
MO,  USA) according to the manufacturer’s instruc-
tions.  Corticosterone data are shown as ng/ml,  and 
were determined in both groups in the presence and 
absence of DEX.
To investigate PTSD-like characteristics such as 
those affecting cognition,  emotion,  and motor activity,  
we subjected other mice to a light/dark box test (to 
assess anxiety),  a Y-maze test (working memory),  a 
cliff avoidance test (visual cognition),  and an open field 
test (locomotor activity) at 1,  4,  8 and 12 weeks after 
the application of the SPS protocol.  The behavioral 
analysis was conducted using 16 mice (control: n=8,  
SPS: n=8) according to a modified form of previous 
methods [9-11].  Briefly,  the light/dark testing was con-
ducted in a box apparatus consisting of a lighted com-
partment and a dark component,  each 40 cm long,  
20 cm high,  and 40 cm wide: each compartment had 
an inner runway (8 cm2).  The mouse was placed in the 
dark compartment at the start time,  and the amount of 
time that the mouse spent in each compartment during 
a 5-min observation period was determined (Fig.1A) [9].
The Y-maze apparatus (Muromachi Kikai,  Tokyo,  
Japan) was based on a black-painted plastic board.  Each 
arm was 40 cm long,  10 cm high,  4 cm wide at the bot-
tom,  and 10 cm wide at the top.  The arms converged to 
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an equilateral triangular central area that was 4 cm at its 
longest axis.  The mouse was placed at the end of one 
arm and allowed to move freely through the maze 
during an 8-min session.  The mouse was considered to 
have entered an arm when it had placed its hind paws 
completely inside it.  Alternation was defined as succes-
sive entries into the three arms,  on overlapping triplet 
sets of test.  The alternation ratio was calculated as the 
ratio of actual to possible alternation (defined as the 
total number of arm entries minus 2) multiplied by 100 
(Fig. 1B) [10].
To examine visual cognition,  we devised a new eval-
uation method,  “the cliff avoidance test”.  The apparatus 
of the cliff avoidance test consisted of 3 areas: an open 
area (a transparent floor; 30 cm╳30 cm╳15 cm),  a 
bench area (a black floor surrounded with a transparent 
wall 10 cm in height; 30 cm╳30 cm╳15 cm),  and a 
start area (10 cm╳4 cm╳7 cm) (Fig. 1C).  The mouse 
was placed in the start area at the start time,  and then 
the amount of time spent in each of the 3 areas was 
recorded using video.  We used the time spent in the 
open area as an index of anxiety-related behavior during 
each 5-min observation.  (Unpublished data).
In the open field test,  the mouse was placed on the 
center of a Hall’s-type open field apparatus (60 cm dia.,  
50 cm high),  and the number of quadrants it entered 
within a 5-min period was counted; the result was then 
regarded as a measure of locomotor activity (Fig. 1D) [11].
The results are presented as means ± standard error 
of the mean (SEM).  The significance of differences 
between groups was tested using a two-way analysis of 
variance (ANOVA) (two experimental groups and four 
time points) with repeated measures.  A p-value < 0.05 
was accepted as denoting a statistically significant dif-
ference.  All analyses were performed with statistical 
analysis software (SPSS ver. 21,  SPSS,  Chicago,  IL,  USA).
Results
Control and SPS-applied mice were tested for a DEX 
suppression of plasma corticosterone at 1,  4,  8 and 
12 weeks after the application of the SPS protocol.  The 
plasma corticosterone levels of the DEX-treated control 
and DEX/SPS-applied mice were significantly lower 
than those of the 2 vehicle-treated groups at all four-
time points after the SPS protocol (Table 1).  A two-way 
ANOVA (the 4 groupsxthe 4 time points) with repeated 
measures showed significance in all three main 
effects: group (F1, 20 = 67.383,  p < 0.01),  time (F3, 20 =  
60.431,  p<0.01),  and group ╳ time (F3, 20 =8.707,  p<0.01).
Moreover,  the application of the SPS protocol sig-
nificantly reduced ratio of DEX- to saline-treated corti-
costerone levels at both 8 and 12 weeks compared to the 
ratio of DEX- to saline-treated corticosterone levels 
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Table 1　 Time course of changes in serum corticosterone levels
1 week 4 weeks 8 weeks 12 weeks
Vehicle-treated control mice 190.5±15.6 164.3±18.8 153.0±16.6 153.1±14.9
DEX-treated control mice 29.2±9.0⁂# 28.2±7.6⁂# 25.3±6.2⁂# 26.0±8.4⁂#
Vehicle-treated SPS-applied mice 169.3±3.8 164.3±16.8 164.4±16.6 140.8±10.3
DEX-treated SPS-applied mice 21.7±3.5⁂# 15.4±2.7⁂# 11.3±2.1⁂# 7.7±1.2⁂#
Each value is the mean±SEM of 6 mice.
⁂p<0.05 vs. the relative Vehicle-treated control group.
#p<0.05 vs. the relative Vehicle-treated SPS-applied group.
A. Light/ dark box test
B. Y-maze test
C. Cliﬀ avoidance test
D. Open-ﬁeld test
Fig.  1　 The apparatuses used in the (A) light/dark box test,  (B) 
Y-maze test,  (C) cliﬀ avoidance test,  and (D) open-ﬁeld test.
between the control and SPS-applied mice (Table 2).  
Thus,  the application of the SPS protocol induced an 
over-suppression of the HPA system by DEX treatment 
in mice.
In the light/dark box test,  the amount of time that 
the SPS-applied mice spent in the lighted compartment 
of the light/dark box was significantly lower at 8 and 
12 weeks after the application of SPS (Fig. 2A).  A two-
way ANOVA (2 groups ╳ 4 time points) with repeated 
measures showed significance in all 3 main effects:  
group (F1, 56 = 21.933,  p < 0.01),  time (F3, 56 = 4.903,  
p < 0.01),  and groupxtime (F3, 56 = 4.872,  p < 0.01).
In the Y-maze test,  the SPS-applied mice tended to 
have a lower alternation ratio at 12 weeks after the 
application of the SPS protocol compared with the con-
trol mice,  but the difference was not significant 
(Fig. 2B).  A two-way ANOVA (2 groups ╳ 4 time 
points) with repeated measures did not reveal a signifi-
cant difference in any of the 3 main effects: group 
(F1, 56 = 0.562,  p > 0.05),  time (F3, 56 = 2.571,  p > 0.05),  
and groupxtime (F3, 56 = 0.530,  p > 0.05).
In the cliff avoidance test,  the SPS-applied mice 
spent significantly less time in the open area only at 
1 week after the SPS protocol (Fig. 2C),  although at 
4 weeks,  both the control and SPS-applied groups had 
gradually and time-dependently spent less time in the 
open area.  A two-way ANOVA (2 groups ╳ 4 time 
points) with repeated measures showed a significant 
main effect of time (F3, 56 = 12.267,  p < 0.01),  but not of 
group (F1, 56 = 1.765,  p > 0.05),  or of group ╳ time (F3, 56 =  
2.582,  p > 0.05).
In the open field test,  the SPS-applied mice tended 
to show reduced locomotor activity in a time-depen-
dent manner until 12 weeks after the application of the 
SPS protocol (Fig. 2D).  A two-way ANOVA (2 
groups ╳ 4 time points) with repeated measures showed 
a significant main effect of time (F3, 56 = 23.511,  
p < 0.01),  but not of group (F1, 56 = 0.057,  p > 0.05),  or of 
group ╳ time (F3, 56 = 0.444,  p > 0.05).
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Table 2　 Time course of changes in the ratio of DEX to vehicle 
in serum corticosterone levels
1 week 4 weeks 8 weeks 12 weeks
Control mice 16.8±5.2 18.0±4.9 17.5±4.3 17.8±5.8
SPS-applied mice 11.8±2.2 9.6±1.6 7.0±1.3⁂ 5.9±0.8⁂
Each value is the mean±SEM of 6 mice.
⁂p<0.05 vs.  the relative control group.
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Fig.  2　 Time course of the changes in the (A) light/dark box test,  (B) Y-maze test,  (C) cliﬀ avoidance test,  and (D) open-ﬁeld test after 
the application of the SPS protocol.  Each value is the mean±SEM of 8 mice.   
⁂p<0.05,  ⁂⁂p<0.01 vs.  the relative control group.
Discussion
The SPS protocol consists of three stresses: re-
straint,  forced swimming,  and ether anesthesia,  which 
correspond to psychological,  physiological,  and endo-
crinological stress,  respectively.  The sequence of 
stresses in the SPS model is somewhat arbitrary and 
does not simulate the common set of traumas experi-
enced by patients with PTSD (i.e.,  the protocol lacks 
ecological validity).  However,  each of the three stresses 
markedly increased the serum corticosterone levels of 
the mice,  and by combining the stresses,  it seemed that 
the SPS model could achieve a severity of symptoms 
similar to that experienced by patients with PTSD such 
as various HPA-axis abnormalities.  The present SPS 
protocol allows us to avoid the risk that habituation 
processes will diminish the effect of a stressor on a 
mouse’s behavior.  We also observed that the application 
of this protocol could lead to enhanced negative feed-
back of the HPA-axis 7 days after its application,  
through time-dependent sensitization (TDS).  This 
endocrinological characteristic,  which has been consis-
tently replicated in the rat SPS model,  is one of the 
advantages of the SPS protocol over other animal mod-
els of PTSD [2 , 3].
In the present study,  the application of the SPS pro-
tocol significantly reduced the ratio of DEX- to saline-
treated corticosterone levels at 8 and 12 weeks,  but not 
at 1 week (7 days).  However,  several previous reports 
suggested that an over-suppression of the HPA system 
by DEX was correlated with the onset of behavioral 
abnormalities including those observed in SPS-applied 
rats tested in a light/dark box [2 , 12].  Our present find-
ings demonstrated that the application of the SPS pro-
tocol in mice also induced an over-suppression of the 
HPA system by DEX treatment similar to that in rats,  
although there are several differences between the 
mouse SPS model and the rat SPS model.  In a rat study,  
it was proposed that the use of an undisturbed period is 
a necessary condition to produce PTSD-like manifesta-
tions [2].
Our present results indicated that marked SPS-
induced behavioral alterations might be recognized at 
8-12 weeks after the application of the SPS protocol,  at 
least in the light/dark box test,  which is commonly used 
to evaluate anxiety-related behavior in rodents.  This test 
is based on rodent’s innate aversion to brightly illumi-
nated areas and on the spontaneous exploratory behav-
ior of rodents in response to mild stressors such as a 
novel environment and light [4].  Thus,  our present 
light/dark box test results suggest that the application of 
the SPS protocol in mice mainly induced anxiety-re-
lated behavior at > 8 weeks after the protocol’s applica-
tion,  similar to the findings in rats,  although there are 
several differences between the mouse and rat SPS mod-
els [2].  Our application of the SPS protocol reduced the 
time that the SPS-applied mice spent in the light com-
partment but not in the dark compartment,  in a 
time-dependent manner until 12 weeks after the SPS 
protocol’s application.  We therefore speculate that the 
application of the SPS protocol may emphasize PTSD-
like anxiety.  We also suspect that mice become habitu-
ated to this light/dark box test because the control mice 
did not display a reduced latency to move from the light 
to the dark compartment of the test box.
We also observed that SPS-induced behavioral alter-
ations in the mice in the cliff avoidance test only at 
1 week after the SPS application,  not at 8-12 weeks.  In 
the previous SPS-applied rat study,  we did not confirm 
to evaluate the effect of the SPS protocol on animal’s 
behavior in the cliff avoidance test.  This test,  which is 
based on the cliff-avoidance reaction,  is an index of 
behavioral teratology in rodents which can be impaired 
by motor,  arousal,  or cognitive dysfunction.  As the 
cliff-avoidance reaction is thought to represent a natural 
tendency of animals to avoid a potential fall from a 
height,  the impairment of the cliff-avoidance reaction 
means that an aspect of maladaptive impulsive behav-
iors in mature rodents may result from deficient behav-
ioral inhibition [13].  The cliff avoidance test is also 
based on the visual cliff avoidance task,  which assesses 
complex visual discrimination learning [14].
Thus,  our results showing that the SPS-applied mice 
spent less and less time in an open area 1 week after the 
SPS may indicate that anxiety-related behavior induced 
by the SPS protocol such as cognitive or impulsive 
behaviors could be recognized prior to true PTSD-like 
symptoms.  In addition,  the results of the SPS applica-
tion on the open field test results in mice may indicate 
no effect of the SPS protocol or habituation to this test,  
because both the control and SPS-applied mice tended 
to show reduced locomotor activity in a time-depen-
dent manner until 12 weeks,  although there was no 
effect on the locomotor activity of the SPS-applied rats 
at least until 2 weeks [15].
Animal models that have 3 types of validity are 
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desired: phenomenological similarity (face validity),  
corresponding theoretical explanatory frameworks 
(construct validity),  and the ability to predict that a 
pharmacological agent with efficacy demonstrated in 
animal studies will have a therapeutic effect in humans 
(predictive validity) [16].  According to previous 
reports,  the rat SPS model had at least the face and 
construct validities as an animal model of PTSD [2].  
However,  the limitations of the rat SPS model are as 
follows: (1) the stressor does not produce PTSD-like 
symptoms in a dose-dependent manner,  (2) reduced 
responsiveness to the stressor has not been well studied,  
and (3) the degree of inter-individual variability in 
response to stressors is still unknown [2].  In addition,  
when attempting to establish a rodent PTSD model,  
one must consider some differences in behavioral char-
acteristics between rats and mice,  such as their anxi-
ety-related behavior,  and it should be noted that differ-
ent experimental methods have often been used in rats 
and mice.
Our present study provides data that support cur-
rently known mechanisms relevant to PTSD because the 
development of a similarly validated mouse model 
emphasizes the benefits and cross-species utility of 
rodent PTSD models; for example,  previous studies 
suggested that characteristics of a mouse SPS model are 
relevant to PTSD and that severe,  multimodal stress 
modifies fear learning in mice,  although strains other 
than ICR (as in the present study) such as Swiss or 
C57BL/6 mice [8, 17].  However,  our present experi-
ments revealed that the application of the SPS protocol 
did not significantly change the alternation behavior 
ratio compared with the control mice in the Y-maze 
test,  since the Y-maze test examined mainly the entire 
working memory rather than only fear memory.  In 
contrast,  the disruption of spatial memory in addition 
to fear memory in SPS-applied was reported; never-
theless,  it should be kept in mind that the details of the 
differences between the characteristics of mice and rats 
as animal models of PTSD are not completely known [18].
Our present findings suggest that the investigation of 
behavioral abnormalities,  mainly regarding cognitive or 
impulsive behaviors revealed in the cliff avoidance test,  
may be useful for finding indications of a PTSD-like 
phenomenon.  However,  further studies are needed to 
evaluate the validity of the SPS mouse model,  for both 
analyses of the pathophysiology of PTSD and investiga-
tions of therapeutic drugs to treat PTSD-like symptoms.  
In particular,  we expect that the time point of 12 weeks 
after the application of the present SPS protocol could 
be useful for animal models of PTSD.
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